TY  - GEN
AU  - Moriwaki,Toshikazu
AU  - Ishida,Hiroyasu
AU  - Araki,Masahiro
AU  - Endo,Shinji
AU  - Yoshida,Shigemasa
AU  - Kobayashi,Mariko
AU  - Hamano,Yukako
AU  - Sugaya,Akinori
AU  - Shimoyamada,Masahiro
AU  - Hasegawa,Naoyuki
AU  - Imanishi,Mamiko
AU  - Ito,Yuka
AU  - Sato,Daiki
AU  - Hyodo,Ichinosuke
TI  - Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancer
SN  - 1868-6982
PY  - 2016///0526
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Biliary Tract Neoplasms
KW  - diagnosis
KW  - Cisplatin
KW  - Deoxycytidine
KW  - Dose-Response Relationship, Drug
KW  - Drug Combinations
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Japan
KW  - epidemiology
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Oxonic Acid
KW  - Retrospective Studies
KW  - Survival Rate
KW  - trends
KW  - Tegafur
KW  - Treatment Outcome
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/jhbp.255
ER  -